The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Low day 100 transplant-related mortality (TRM) and relapse rate following clofarabine (CLO) in combination with cytarabine, total body irradiation (TBI), and allogeneic stem cell transplantation (AlloSCT) in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.
Kavita Radhakrishnan
No relevant relationships to disclose
Angela M Ricci
No relevant relationships to disclose
Mark B Geyer
No relevant relationships to disclose
Lauren Harrison
No relevant relationships to disclose
Deirdre Duffy
No relevant relationships to disclose
Mehmet Fevzi Ozkaynak
No relevant relationships to disclose
Prakash Satwani
No relevant relationships to disclose
Alexandra C Cheerva
No relevant relationships to disclose
Julie Talano
No relevant relationships to disclose
Theodore Moore
No relevant relationships to disclose
Alfred P Gillio
No relevant relationships to disclose
Randal K. Wada
No relevant relationships to disclose
Lee Ann Baxter-Lowe
No relevant relationships to disclose
Mitchell S. Cairo
Research Funding - Genzyme